Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Blueprint Medicines (BPMC)
NASDAQ:BPMC
Holding BPMC?
Track your performance easily
See the Price Targets and Ratings of:
BPMC Analyst Ratings
Moderate Buy
9 Buy
5 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
BPMC Stock 12 Month Forecast
Average Price Target
$122.85
▲(30.48% Upside)
| Highest Price Target$155.00 | Average Price Target$122.85 | Lowest Price Target$88.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
JMP Securities
Reiterated
11/18/24
TD Cowen
Reiterated
11/15/24
H.C. Wainwright
Reiterated
11/15/24
Needham
Reiterated
11/15/24
Morgan Stanley
Reiterated
11/14/24
J.P. Morgan
Initiated
11/14/24
Barclays
Reiterated
11/05/24
Leerink Partners
Reiterated
10/31/24
Wells Fargo
Assigned
10/30/24
Stifel Nicolaus
Reiterated
10/30/24
Oppenheimer
$130
Buy
38.08%
Upside
Reiterated
10/30/24
Blueprint management moves maybe made with buyer in mind, says OppenheimerBlueprint management moves maybe made with buyer in mind, says Oppenheimer
UBS
$88
Hold
-6.53%
Downside
Initiated
10/24/24
Blueprint Medicines initiated with a Neutral at UBSBlueprint Medicines initiated with a Neutral at UBS
Piper Sandler
$109
Hold
15.77%
Upside
Assigned
10/23/24
Piper Sandler Sticks to Its Hold Rating for Blueprint Medicines (BPMC)
Goldman Sachs
―
Buy
―
Reiterated
08/01/24
Blueprint Medicines: A Strong Buy on Ayvakit's Success and Promising Pipeline
Robert W. Baird
$112→$127
Buy
34.89%
Upside
Reiterated
08/01/24
Blueprint Medicines price target raised to $127 from $112 at BairdBlueprint Medicines price target raised to $127 from $112 at Baird
Best Analysts Covering Blueprint Medicines
Which Analyst Should I Follow If I Want to Buy BPMC and Sell After:
1 Month
xxx
Success Rate
11/16 ratings generated profit
Average Return
+2.48%
reiterated a xxx
rating 10 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 68.75% of your transactions generating a profit, with an average return of +2.48% per trade.
3 Months
xxx
Success Rate
9/13 ratings generated profit
Average Return
+9.50%
assigned a xxx
rating 24 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 69.23% of your transactions generating a profit, with an average return of +9.50% per trade.
1 Year
Success Rate
11/13 ratings generated profit
Average Return
+34.84%
reiterated a buy rating 8 days ago
Copying Andrew Fein's trades and holding each position for 1 Year would result in 84.62% of your transactions generating a profit, with an average return of +34.84% per trade.
2 Years
xxx
Success Rate
14/16 ratings generated profit
Average Return
+41.50%
reiterated a xxx
rating 10 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 87.50% of your transactions generating a profit, with an average return of +41.50% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
BPMC Analyst Recommendation Trends
Rating
Jul 24
Aug 24
Sep 24
Oct 24
Nov 24
Strong Buy
1
3
5
9
8
Buy
14
14
10
12
7
Hold
7
6
6
10
9
Sell
1
0
0
0
0
Strong Sell
0
0
0
0
0
total
23
23
21
31
24
Each month's total comprises the sum of three months' worth of ratings.
BPMC Financial Forecast
BPMC Stock Forecast FAQ
What is BPMC’s average 12-month price target, according to analysts?
Based on analyst ratings, Blueprint Medicines’s 12-month average price target is $122.85.
What is BPMC’s upside potential, based on the analysts’ average price target?
Blueprint Medicines has 30.48% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is BPMC a Buy, Sell or Hold?
Blueprint Medicines has a consensus rating of Moderate Buy which is based on 9 buy ratings, 5 hold ratings and 0 sell ratings.
What is Blueprint Medicines’s price target?
The average price target for Blueprint Medicines is $122.85. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $155.00 ,the lowest forecast is $88.00. The average price target represents 30.48% Increase from the current price of $94.15.
The highest analyst price target is $155.00 ,the lowest forecast is $88.00. The average price target represents 30.48% Increase from the current price of $94.15.
What do analysts say about Blueprint Medicines?
Blueprint Medicines’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 14 Wall Streets Analysts.
How can I buy shares of BPMC?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.